Scientists develop test that will help prevent glaucoma-related blindness

Published:

Australian researchers have identified 107 genes that increase a person’s risk of developing the eye disease glaucoma, and developed a genetic test to detect those at risk of going blind from it.

The research, led by QIMR Berghofer Medical Research Institute and Flinders University, has been published today in the journal Nature Genetics.

The researchers now want 20,000 people to sign up to their Genetics of Glaucoma Study so they can find more genes involved in the disease.

Glaucoma is a group of diseases that are characterised by progressive damage and degeneration of the optic nerve, causing gradual loss of vision.

It is the leading cause of irreversible blindness worldwide and is predicted to affect 76 million people by 2020.

Although there is no cure for glaucoma, treatment can reliably slow or halt the rate of disease progression in most cases. Up to 50 per cent of people with the disease do not know they have it.

Lead researcher and the head of QIMR Berghofer’s Statistical Genetics Group, Associate Professor Stuart MacGregor, said identifying the new genes has allowed the researchers to develop a glaucoma polygenic risk score (PRS) that can predict who is likely to get the eye disease.

“Glaucoma is a genetic disease and the best way to prevent the loss of sight from glaucoma is through early detection and treatment,” Associate Professor MacGregor said.

“Our study found that by analysing DNA collected from saliva or blood, we could determine how likely a person was to develop the disease and who should be offered early treatment and/or monitoring.

“Importantly, unlike existing eye health checks that are based on eye pressure or optic nerve damage, the genetic test can be done before damage begins so regular screening can be put in place.

“Having a high risk score doesn’t mean you will definitely get glaucoma, but knowing you could be at future risk allows people to take the necessary precautions.”

Clinical lead researcher and Chair and Academic Head of the Department of Ophthalmology at Flinders University, Professor Jamie Craig, said the study results provided hope that mass screening for glaucoma could be offered in the future. 

“There are Australians who, if they’d had appropriate treatment a few years earlier, wouldn’t have gone blind,” said Professor Craig, who is also a consultant ophthalmologist.

“One in 30 Australians has glaucoma, but most people only find out they have it when they go to the optometrist because they are losing vision, or for a general eye check.

“Early detection is paramount because existing treatments can’t restore vision that has been lost, and late detection of glaucoma is a major risk factor for blindness.

“Glaucoma can arise at any age but most of those affected are in their 50s or older, so our ultimate aim is to be able to offer blood tests to people when they turn 50 so they can find out if they are at risk, and then hopefully act on it.

“In most cases, glaucoma can be treated easily using simple eye drops, but this test is likely to be helpful in identifying those who would benefit from more aggressive intervention such as surgery."

The researchers are now hoping to recruit 20,000 people with a personal or family history of the disease to join their Genetics of Glaucoma Study so that they can identify more genes that play a role in the condition.

“We want to know who will get glaucoma, and for those who are susceptible, we want to be able to pinpoint at what age they’re going to get it,” Associate Professor MacGregor said.

“That would allow us to develop a personalised approach for earlier treatment of high-risk individuals, and means people at lower risk could have less intensive monitoring and treatment. This would have benefits for patients, doctors and the health care system with reduced interventions and reduced costs.”

Australians interested in taking part in the research can visit the Genetics of Glaucoma study website www.qimrberghofer.edu.au/genetics-of-glaucoma, phone 07 3845 3981 or email Glaucoma_Genetics@qimrberghofer.edu.au. (The website will go live on Tuesday 21 January.)

The research has been funded by the National Health and Medical Research Council.

The study findings can be accessed on the Nature Genetics website.

 
Community Science & Research
Social:   

QIMR Berghofer Medical Research Institute :
PO Royal Brisbane Hospital, Brisbane, QLD, 4029, Brisbane
07 3845 3752
QIMR Berghofer Medical Research Institute
Showing 10+ recent articles for this business
Scientists identify new target for melanoma immunotherapy 30 June 2020 | QIMR Berghofer research has found a new reason why some melanoma patients do not respond well to immunotherapy – a discovery that could lead to better-tailored treatments for the potentially deadly cancer. More information...
Heart research to be revolutionised thanks to $8 million funding boost 25 June 2020 | Queensland researchers will begin developing a comprehensive ‘encyclopedia’ of the heart in a world-first project that, if successful, will revolutionise cardiac research and treatment. More information...
Researchers stimulate improvements in Parkinson's treatment 23 June 2020 | New research led by QIMR Berghofer Medical Research Institute has identified ways to make the most widely-used advanced treatment for Parkinson’s disease – deep brain stimulation therapy – more effective and... More information...
Blood cancer find raises new treatment hopes 16 June 2020 | New QIMR Berghofer research has identified how an early genetic change in blood and bone marrow cells paves the way for the development of some blood cancers. More information...
New evidence of dangers of high-fat diet on pre-cancerous condition 08 June 2020 | New QIMR Berghofer research indicates that a high-fat diet over a long period of time may induce early Barrett’s oesophagus, a precursor condition to oesophageal cancer. More information...
Study finds new clues in eye cancer 19 May 2020 | About five per cent of melanomas in the eye are caused by exposure to sunlight, while the majority are not, a new study by QIMR Berghofer and Queensland Ocular Oncology Service has found. More information...
Queenslanders needed to help find potential COVID-19 immunotherapy treatment 14 May 2020 | QIMR Berghofer scientists are urging Queenslanders who have recovered from COVID-19 to help them discover how the human immune system fights the disease – and hopefully develop immunotherapies to treat very sick... More information...
Scientists to trial rheumatoid arthritis drug in ICU patients with COVID-19 09 May 2020 | Queensland researchers are preparing to begin a clinical trial of a drug that regulates inflammation in the hope it may help save the lives of critically ill patients with COVID-19. More information...
Scientists double understanding of genetic risk of melanoma 28 April 2020 | A global collaboration of scientists has more than doubled the known number of regions on the human genome that influence the risk of developing melanoma. More information...


comments powered by Disqus

All articles submitted by third parties or written by My Sunshine Coast come under our Disclaimer / Terms of Service